Philippe Slos

1.0k total citations
26 papers, 805 citations indexed

About

Philippe Slos is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Philippe Slos has authored 26 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Philippe Slos's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers) and Probiotics and Fermented Foods (8 papers). Philippe Slos is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers) and Probiotics and Fermented Foods (8 papers). Philippe Slos collaborates with scholars based in France, Belgium and United States. Philippe Slos's co-authors include Annick Mercenier, Bruce Acres, Patrick Squiban, Stéphane Paul, Margaret Liu, Jean‐Marc Balloul, Nadine Bizouarne, Yves Lemoine, Dennis Romero and Catherine Robert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Philippe Slos

25 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Slos France 17 370 287 254 211 159 26 805
Alice S.-Y. Ho United States 5 172 0.5× 259 0.9× 165 0.6× 67 0.3× 152 1.0× 7 803
Riccardo Guidi Sweden 10 276 0.7× 169 0.6× 108 0.4× 89 0.4× 97 0.6× 12 658
Paola Paglia Italy 16 433 1.2× 909 3.2× 217 0.9× 300 1.4× 92 0.6× 27 1.5k
Kimberly Shafer-Weaver United States 17 188 0.5× 668 2.3× 204 0.8× 308 1.5× 165 1.0× 22 1.3k
Drew M. Catron United States 10 206 0.6× 689 2.4× 70 0.3× 81 0.4× 78 0.5× 11 1.0k
Meike Wendland Germany 10 211 0.6× 543 1.9× 96 0.4× 136 0.6× 36 0.2× 11 897
David Ruano‐Gallego Spain 17 487 1.3× 118 0.4× 240 0.9× 140 0.7× 65 0.4× 30 946
Reyes S. Taméz-Guerra Mexico 13 195 0.5× 274 1.0× 40 0.2× 138 0.7× 85 0.5× 29 604
Sarah Murdoch United Kingdom 8 274 0.7× 262 0.9× 111 0.4× 34 0.2× 40 0.3× 8 901
Joachim Fensterle Germany 14 202 0.5× 341 1.2× 90 0.4× 100 0.5× 33 0.2× 21 668

Countries citing papers authored by Philippe Slos

Since Specialization
Citations

This map shows the geographic impact of Philippe Slos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Slos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Slos more than expected).

Fields of papers citing papers by Philippe Slos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Slos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Slos. The network helps show where Philippe Slos may publish in the future.

Co-authorship network of co-authors of Philippe Slos

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Slos. A scholar is included among the top collaborators of Philippe Slos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Slos. Philippe Slos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maubant, Sylvie, et al.. (2018). Abstract 5010: Advantages in using orthotopic syngeneic tumor models to evaluate immune-based approaches for cancer treatment. Cancer Research. 78(13_Supplement). 5010–5010.
2.
Hillman, Gilda G., Lisa Abernathy‐Close, Matthew D. Fountain, et al.. (2017). Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen. Journal for ImmunoTherapy of Cancer. 5(1). 4–4. 19 indexed citations
3.
Bichat, Francis, Sylvie Maubant, Jean‐François Mirjolet, et al.. (2017). Abstract 2669: Antitumor activity of the CMP-001 (TLR9 agonist) alone or combined with immune modulators in syngeneic tumor models. Cancer Research. 77(13_Supplement). 2669–2669. 2 indexed citations
4.
Fend, Laetitia, Nathalie Accart, Jacqueline Kintz, et al.. (2013). Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts. PLoS ONE. 8(9). e73310–e73310. 59 indexed citations
5.
Dummer, Reinhard, Christoph Rochlitz, Thierry Velu, et al.. (2008). Intralesional Adenovirus-mediated Interleukin-2 Gene Transfer for Advanced Solid Cancers and Melanoma. Molecular Therapy. 16(5). 985–994. 39 indexed citations
6.
Liu, Margaret, Bruce Acres, Jean‐Marc Balloul, et al.. (2004). Gene-based vaccines and immunotherapeutics. Proceedings of the National Academy of Sciences. 101(suppl_2). 14567–14571. 137 indexed citations
7.
Dummer, Reinhard, Jessica C. Hassel, Stefan B. Eichmüller, et al.. (2004). Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas. Blood. 104(6). 1631–1638. 82 indexed citations
8.
Hillman, Gilda G., Philippe Slos, Yu Wang, et al.. (2003). Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Therapy. 11(1). 61–72. 18 indexed citations
9.
Hillman, Gilda G., Nikoletta L. Kallinteris, Philippe Slos, et al.. (2003). Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells. Gene Therapy. 10(17). 1512–1518. 16 indexed citations
10.
Khorana, Alok A., Joseph D. Rosenblatt, Deepak M. Sahasrabudhe, et al.. (2003). A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Therapy. 10(4). 251–259. 49 indexed citations
11.
12.
Leroy, Pierre, Philippe Slos, Horst E. Homann, et al.. (1998). Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes. Research in Immunology. 149(7-8). 681–684. 13 indexed citations
13.
Slos, Philippe, Deborah Prozzi, Marie-Paule Kiény, et al.. (1998). Production of cholera toxin B subunit inLactobacillus. FEMS Microbiology Letters. 169(1). 29–36. 33 indexed citations
14.
Hols, Pascal, et al.. (1997). Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826. Microbiology. 143(8). 2733–2741. 40 indexed citations
15.
Slos, Philippe, Denis Speck, Nathalie Accart, et al.. (1994). Recombinant Cholera Toxin B-Subunit in Escherichia coli: High-Level Secretion, Purification, and Characterization. Protein Expression and Purification. 5(5). 518–526. 25 indexed citations
16.
Dalemans, Wilfried, Jocelyne Hinnrasky, Philippe Slos, et al.. (1992). Immunocytochemical analysis reveals differences between the subcellular localization of normal and ΔPhe508 recombinant cystic fibrosis transmembrane conductance regulator. Experimental Cell Research. 201(1). 235–240. 19 indexed citations
17.
Boizet, Brigitte, Dominique Villeval, Philippe Slos, et al.. (1988). Isolation and structural analysis of the phospho-β-galactosidase gene from Streptococcus lactis Z268. Gene. 62(2). 249–261. 41 indexed citations
18.
19.
Mercenier, Annick, Philippe Slos, Michel Faelen, & J. P. Lecocq. (1988). Plasmid transduction in Streptococcus thermophilus. Molecular and General Genetics MGG. 212(2). 386–389. 19 indexed citations
20.
Romero, Dennis, et al.. (1987). Conjugative mobilization as an alternative vector delivery system for lactic streptococci. Applied and Environmental Microbiology. 53(10). 2405–2413. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice S.-Y. Ho Breakdown of academic impact, for papers by Riccardo Guidi Breakdown of academic impact, for papers by Paola Paglia Breakdown of academic impact, for papers by Kimberly Shafer-Weaver Breakdown of academic impact, for papers by Drew M. Catron Breakdown of academic impact, for papers by Meike Wendland Breakdown of academic impact, for papers by David Ruano‐Gallego Breakdown of academic impact, for papers by Reyes S. Taméz-Guerra Breakdown of academic impact, for papers by Sarah Murdoch Breakdown of academic impact, for papers by Joachim Fensterle
Rankless by CCL
2026